Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood-2017-09-801498
PubMed Identifier: 29330221
Publication URI: http://europepmc.org/abstract/MED/29330221
Type: Journal Article/Review
Volume: 131
Parent Publication: Blood
Issue: 12
ISSN: 0006-4971